Search results
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial
Investing.com· 2 days agoThe company reported the completion of patient enrollment ahead of schedule for its SUNRISE-3 global...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 9 hours agoAs the earnings come to an end in the ongoing reporting cycle, the focus shifts to pipeline and...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 hours agoToday, the Biden-Harris Administration announced that during their three-plus years in office, historically Black colleges and universities (HBCUs) have received over $16 ...
What’s driving the anti-vax movement? | The Excerpt
USA Today· 5 days agoCORRECTION: This episode has been updated to remove an incorrect reference to the HPV vaccine. On Sunday’s episode of The Excerpt podcast: Whether...
Stock market today: Dow tops 40,000 for the first time as Wall Street drifts higher | amNewYork
amNewYork· 8 hours agoThe Dow was up 106 points, or 0.3%, at 40,014, in midday trading. It made its last leap of 10,000...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 7 hours agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar ...
A tale of two nurses: How average travel nurse compensation compares to all US nurse salaries
Stacker via AOL· 2 days agoShutterstock // Gorodenkoff Heightened demand made nursing a high-paying profession over the last...
Is this GOP candidate standing up to 'cancel culture' or defending racists?
Cincinnati.com | The Enquirer via Yahoo News· 24 hours agoRoberts said he disagrees with that idea, but he admires Luther's anti-lockdown stance during the ...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 1 day agoCEO David Dodd discussed significant advancements in the company's Phase 2 clinical trials,...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19...